Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > The ROT in Spectral, a Casual Observation

<< Previous

Bullboard Posts

Next >>

Post by Gorf79on Aug 26, 2022 10:13am

330 Views

Post# 34922226

The ROT in Spectral, a Casual Observation

At 42 cents PMX is valued at a roughly 97% probability of failure.

Below are the valuations attached to recent news releases:

The Arc Dialysis Deal - Worthless

FDA Breakthrough Designation - Worthless

Department of Veterans Affairs Deal - Worthless

After 20 years of unmitigated failure in properly valuing Spectral isn't it time to expect better... to do better?

There is Rot in Spectral.

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023